|
Volumn 19, Issue 10, 1998, Pages 415-423
|
Chronic obstructive pulmonary disease: New opportunities for drug development
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
ANTIOXIDANT;
AUTACOID;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
BUDESONIDE;
CELL ADHESION MOLECULE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
COLCHICINE;
CORTICOSTEROID;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INTERLEUKIN 10;
LEUKOCYTE ELASTASE INHIBITOR;
LEUKOTRIENE B4 RECEPTOR ANTAGONIST;
MACROLIDE;
MATRIX METALLOPROTEINASE INHIBITOR;
MISOPROSTOL;
MONOCLONAL ANTIBODY;
MUCOLYTIC AGENT;
PHOSPHODIESTERASE INHIBITOR;
PROTEINASE;
PROTEINASE INHIBITOR;
TACHYKININ RECEPTOR ANTAGONIST;
TIOTROPIUM BROMIDE;
UNINDEXED DRUG;
AIRWAY OBSTRUCTION;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
CYTOLOGY;
DRUG DESIGN;
DRUG TARGETING;
GENE REPRESSION;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
MOLECULAR BIOLOGY;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PREVALENCE;
PRIORITY JOURNAL;
REVIEW;
SMOKING CESSATION;
ADRENERGIC BETA-AGONISTS;
ANTI-BACTERIAL AGENTS;
ANTI-INFLAMMATORY AGENTS;
BRONCHODILATOR AGENTS;
HUMANS;
LUNG DISEASES, OBSTRUCTIVE;
MACROLIDES;
PHOSPHODIESTERASE INHIBITORS;
SMOKING CESSATION;
|
EID: 0032191115
PISSN: 01656147
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-6147(98)01245-0 Document Type: Review |
Times cited : (51)
|
References (78)
|